sydney prostate


First and foremost I am a clinician and surgeon with a particular expertise and passion for the treatment of patients with prostate cancer and benign prostate conditions. I do this in three ways: firstly as your doctor or surgeon, secondly through the research I perform with my highly skilled team and thirdly by offering a comprehensive second opinion service. My […]

Home Read More »

Focal Irreversible Electroporation

NanoKnife© IRE Results We have now treated 450 patients since February 2013. All patients have been meticulously followed up (100% follow up) with high-quality MRIs and biopsies, in addition to being offered validated quality of life questionnaires. Our current outcomes for focal irreversible electroporation in the primary setting (not after radiotherapy) is: We are currently conducting

Focal Irreversible Electroporation Read More »

Focal Therapy

Focal therapy for selective patients with prostate cancer is a relatively new treatment for a select group of patients for the treatment of localised prostate cancer. The treatment is recommended for patients with localised prostate cancer stage T1 and T2 who are not candidates for prostatectomy because of their age, their general state of being

Focal Therapy Read More »

PSMA PET/CT Scanning

PSMA PET scanning is a relatively new diagnostic technology that greatly assists in localising the extent of prostate cancer. It can do this not only in the area of the prostate but also in the lymph glands and bones. As a result, therapy can be targeted more appropriately. PSMA PET/CT scanning is much more accurate

PSMA PET/CT Scanning Read More »

Multiparametric MRI

Recent developments in magnetic resonance imaging (MRI) have improved the ability of MRI to detect tumours, stage cancer and help in management decisions. They are also helping to more accurately target biopsies. What has changed in MRI imaging to make it so accurate? MRI has advanced recently so that not only can we look at

Multiparametric MRI Read More »

Benign Prostatic Enlargement

Benign prostatic enlargement is the non-cancerous enlargement of the prostate. It refers to benign prostatic hyperplasia (increase in the number of cells) or hypertrophy (increase in cell size). Benign prostatic enlargement is the most common prostate disease in men. Typically, the prostate grows to the size of a walnut, but may begin to grow again

Benign Prostatic Enlargement Read More »


Cystoscopy is an endoscopic procedure where a tube is inserted into the urethra through the opening at the end of the penis. It allows me to visually examine the complete length of the urethra and the bladder for polyps, strictures, abnormal growths and other problems. Why is the test is performed? How does the test

Cystoscopy Read More »

Open Surgery Results

I continue to perform open radical prostatectomy in several situations. Firstly, where robotic prostatectomy is difficult to perform, such as a patient who has extensive adhesions. Robotic is also not the best option where the cancer is extremely extensive and tactile sensation is beneficial. Having performed over 3,500 open radical prostatectomies I have noticed that,

Open Surgery Results Read More »


{mosmap width =’644’|height =’360’|align=’bottom’|sv=’bottom’|lat=’-33.880946’|lon=’151.219201’|svyaw=’150.69’|svzoom=’0’|svpitch=’-4.38’|lightbox=’0’| zoom=’16’|zoomType=’Large’|zoomNew=’0’|mapType=’Normal’|showMaptype=’0’| overview=’0’|marker=’1’|text='<div style=width:268px;height:80px;>Suite 1001, St Vincent’s Clinic<br />438 Victoria Street, Darlinghurst, NSW 2010<br />Australia </div>’}’

Location Read More »


Advocacy As an author of educational documents my main objectives have been to highlight the prevalence of prostate cancer, the importance of early detection and the available treatment options. Awareness initiatives such as the original Movember fundraiser through to the Prostate Cancer Foundation of Australia’s, ‘Be a Man’ campaign are an important part of the fight

Advocacy Read More »

Active Surveillance

Active surveillance involves the careful monitoring of prostate cancer progression in patients with less aggressive tumours. An increasing proportion of patients with Gleason 6 cancers, particularly in the older age group, are having their tumours monitored. Monitoring involves four-monthly prostate specific antigen (PSA) testing, a repeat biopsy every 12 to18 months and then ongoing monitoring

Active Surveillance Read More »


HDR High dose rate (HDR) brachytherapy involves the placement of wires into the prostate to deliver high doses of radiation directly into the prostate. Three treatments are given over a 36-hour period and are intended for patients with advanced prostate cancer. By delivering a higher dose it is more likely to cure more aggressive cancers

Brachytherapy Read More »